HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A surveillance study of adenovirus infection in adult solid organ transplant recipients.

Abstract
Little is known about adenovirus infections in adult organ transplant recipients. We prospectively assessed adenovirus infection in 263 transplant recipients using polymerase chain reaction (PCR) on plasma samples at regular intervals post-transplant. Adenovirus DNA was detected in 19 of 263 patients (7.2%). Viremia by transplant type was: liver (n = 10 of 121 [8.3%]), kidney (n = 6 of 92 [6.5%]) and heart (n = 3 of 45 [6.7%]). Time to viremia onset was within 10 days post-transplant (n = 4), on day 28 (n = 1), on day 100 (n = 7) and between months 6 and 12 (n = 7). At the time of viremia, 11 of 19 (58%) patients had no symptoms, 2 of 19 (10.5%) had gastrointestinal (GI) symptoms, 2 of 19 (10.5%) had respiratory symptoms and 4 patients (21%) had vague/non-specific symptoms. All patients recovered spontaneously. Only 1 of 19 (5%) patients had subsequent acute rejection. Adenovirus viremia is relatively common in adult liver, kidney and heart transplant recipients and most infections are asymptomatic, transient and self-limited. No serious clinical sequelae or effects on subsequent acute rejection were observed.
AuthorsAtul Humar, Deepali Kumar, Tony Mazzulli, Raymund R Razonable, George Moussa, Carlos V Paya, Emma Covington, Emma Alecock, Mark D Pescovitz, PV16000 Study Group
JournalAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Am J Transplant) Vol. 5 Issue 10 Pg. 2555-9 (Oct 2005) ISSN: 1600-6135 [Print] United States
PMID16162207 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Antiviral Agents
  • DNA Primers
  • DNA, Viral
  • Immunosuppressive Agents
  • Valganciclovir
  • Ganciclovir
Topics
  • Adenoviridae (metabolism, pathogenicity)
  • Adenoviridae Infections (diagnosis)
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Antiviral Agents (therapeutic use)
  • Cohort Studies
  • DNA Primers (chemistry)
  • DNA, Viral (metabolism)
  • Double-Blind Method
  • Female
  • Ganciclovir (administration & dosage, analogs & derivatives)
  • Heart (virology)
  • Heart Transplantation (adverse effects)
  • Humans
  • Immunosuppressive Agents (administration & dosage)
  • Kidney (virology)
  • Kidney Transplantation (adverse effects)
  • Liver (virology)
  • Liver Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Organ Transplantation (adverse effects)
  • Polymerase Chain Reaction
  • Postoperative Complications
  • Prospective Studies
  • Time Factors
  • Valganciclovir

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: